Clinical Trial Accrual Targeting Genomic Alterations After Next-Generation Sequencing at a Non-National Cancer Institute–Designated Cancer Program We distributed a 21-item survey on cancer screening ...

Post-COVID-19, colonoscopy and FIT usage declined, while stool DNA testing increased among privately insured adults. Screening preferences varied by sex, socioeconomic status, and metropolitan versus ...

Screening is a key component of breast cancer early detection programs that can considerably reduce relevant mortality rates. The purpose of this study was to determine the breast cancer screening ...

Adherence with the multitarget stool DNA test for colorectal cancer screening in rural southeastern Kentucky. This is an ASCO Meeting Abstract from the 2022 ASCO Gastrointestinal Cancers Symposium.

Aflac hopes that every time you see a checkered pattern, you’ll be reminded to get checked for cancer. That’s one ambitious aim of the insurer’s new "Check for Cancer" initiative, which Chief ...